Philips, established in 1891 and headquartered in Amsterdam, Netherlands, is a global leader in health technology, committed to improving people's health and well-being through meaningful innovation. The company's portfolio includes diagnostic imaging, image-guided therapy, patient monitoring, health informatics, and consumer health and home care products. Philips aims to improve 2.5 billion lives per year by 2030, including 400 million in underserved communities. Recognized for its commitment to sustainability and social responsibility, Philips has been named a top employer by Forbes and ranked as the highest medical technology company among Clarivate's Top 100 Global Innovators in 2025.
Philips' new diagnostic viewer offers rapid, secure access to medical imaging data from anywhere, enhancing workflow efficiency and enabling informed clinical decisions across healthcare enterprises.
The integration adds automated volumetrics, lesion quantification, and tumor-tracking analytics directly into Philips MR systems to deliver faster, reproducible, data-driven brain assessments.
DeviceGuide's AI tracks the tiny heart repair device using combined live echo/X-ray, creating a real-time 3D model superimposed on the beating heart for clear navigation.
New integration links Philips Advanced Visualization Workspace with Azurion system, automatically matching CT anatomy to C-arm movement for real-time 3D guidance and improved PCI workflow efficiency.
Developed with Dr. Justin Davies and powered by Cerebria, the adaptive platform delivers case-based, multilingual IVUS education worldwide, accelerating image interpretation skills and improving care outcomes.
Through Project SEARCH, Philips develops realistic algorithm-generated CT and MRI datasets that enhance AI accuracy, protect patient privacy, and build clinician trust across oncology and cardiovascular applications.
Partnership integrates connected Philips AEDs into Securitas’ guarding solutions, ensuring monitored devices, trained responders, and faster action during sudden cardiac arrests in workplaces and public areas.
Global adoption milestone highlights advanced imaging efficiency, supporting over 15 million patient treatments annually across 170+ countries since Zenition’s 2019 launch.